Literature DB >> 28462521

RIPK3 in cell death and inflammation: the good, the bad, and the ugly.

Susana Orozco1,2, Andrew Oberst1,3.   

Abstract

Necroptosis is a form of cell death that can be observed downstream of death receptor or pattern recognition receptor signaling under certain cellular contexts, or in response to some viral and bacterial infections. The receptor interacting protein kinases-1 (RIPK1) and RIPK3 are at the core of necroptotic signaling, among other proteins. Because this pathway is normally halted by the pro-apoptotic protease caspase-8 and the IAP ubiquitin ligases, how and when necroptosis is triggered in physiological settings are ongoing questions. Interestingly, accumulating evidence suggests that RIPK3 has functions beyond the induction of necroptotic cell death, especially in the areas of tissue injury and sterile inflammation. Here, we will discuss the role of RIPK3 in a variety of physiological conditions, including necroptotic and non-necroptotic cell death, in the context of viral and bacterial infections, tissue damage, and inflammation.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  RIPK3; cell death; infection; inflammation; necroptosis; tissue damage

Mesh:

Substances:

Year:  2017        PMID: 28462521      PMCID: PMC5419046          DOI: 10.1111/imr.12536

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  104 in total

Review 1.  TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target.

Authors:  M Obayed Ullah; Matthew J Sweet; Ashley Mansell; Stuart Kellie; Bostjan Kobe
Journal:  J Leukoc Biol       Date:  2016-05-09       Impact factor: 4.962

2.  RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus.

Authors:  Shoko Nogusa; Roshan J Thapa; Christopher P Dillon; Swantje Liedmann; Thomas H Oguin; Justin P Ingram; Diego A Rodriguez; Rachelle Kosoff; Shalini Sharma; Oliver Sturm; Katherine Verbist; Peter J Gough; John Bertin; Boris M Hartmann; Stuart C Sealfon; William J Kaiser; Edward S Mocarski; Carolina B López; Paul G Thomas; Andrew Oberst; Douglas R Green; Siddharth Balachandran
Journal:  Cell Host Microbe       Date:  2016-06-16       Impact factor: 21.023

3.  RIP3, a novel apoptosis-inducing kinase.

Authors:  X Sun; J Lee; T Navas; D T Baldwin; T A Stewart; V M Dixit
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

4.  RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.

Authors:  Marius Dannappel; Katerina Vlantis; Snehlata Kumari; Apostolos Polykratis; Chun Kim; Laurens Wachsmuth; Christina Eftychi; Juan Lin; Teresa Corona; Nicole Hermance; Matija Zelic; Petra Kirsch; Marijana Basic; Andre Bleich; Michelle Kelliher; Manolis Pasparakis
Journal:  Nature       Date:  2014-08-17       Impact factor: 49.962

5.  The essential role of MEKK3 in TNF-induced NF-kappaB activation.

Authors:  J Yang; Y Lin; Z Guo; J Cheng; J Huang; L Deng; W Liao; Z Chen; Z Liu; B Su
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

6.  Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.

Authors:  Kim Newton; Debra L Dugger; Katherine E Wickliffe; Neeraj Kapoor; M Cristina de Almagro; Domagoj Vucic; Laszlo Komuves; Ronald E Ferrando; Dorothy M French; Joshua Webster; Merone Roose-Girma; Søren Warming; Vishva M Dixit
Journal:  Science       Date:  2014-02-20       Impact factor: 47.728

7.  RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.

Authors:  Yasushi Ito; Dimitry Ofengeim; Ayaz Najafov; Sudeshna Das; Shahram Saberi; Ying Li; Junichi Hitomi; Hong Zhu; Hongbo Chen; Lior Mayo; Jiefei Geng; Palak Amin; Judy Park DeWitt; Adnan Kasim Mookhtiar; Marcus Florez; Amanda Tomie Ouchida; Jian-bing Fan; Manolis Pasparakis; Michelle A Kelliher; John Ravits; Junying Yuan
Journal:  Science       Date:  2016-08-05       Impact factor: 47.728

8.  Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4.

Authors:  Kim Newton; Xiaoqing Sun; Vishva M Dixit
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  RIP3 Regulates Autophagy and Promotes Coxsackievirus B3 Infection of Intestinal Epithelial Cells.

Authors:  Katharine G Harris; Stefanie A Morosky; Coyne G Drummond; Maulik Patel; Chonsaeng Kim; Donna B Stolz; Jeffrey M Bergelson; Sara Cherry; Carolyn B Coyne
Journal:  Cell Host Microbe       Date:  2015-08-12       Impact factor: 21.023

10.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

View more
  40 in total

Review 1.  Regulation of present and future development by maternal regulatory signals acting on the embryo during the morula to blastocyst transition - insights from the cow.

Authors:  Peter J Hansen; Paula Tríbulo
Journal:  Biol Reprod       Date:  2019-09-01       Impact factor: 4.285

Review 2.  Collateral damage: necroptosis in the development of lung injury.

Authors:  Hilary Faust; Nilam S Mangalmurti
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-27       Impact factor: 5.464

3.  Outcomes of RIP Kinase Signaling During Neuroinvasive Viral Infection.

Authors:  Brian P Daniels; Andrew Oberst
Journal:  Curr Top Microbiol Immunol       Date:  2020-04-07       Impact factor: 4.291

4.  The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in Neurons.

Authors:  Brian P Daniels; Sigal B Kofman; Julian R Smith; Geoffrey T Norris; Annelise G Snyder; Joseph P Kolb; Xia Gao; Jason W Locasale; Jennifer Martinez; Michael Gale; Yueh-Ming Loo; Andrew Oberst
Journal:  Immunity       Date:  2019-01-08       Impact factor: 31.745

Review 5.  Necroptosis: a crucial pathogenic mediator of human disease.

Authors:  Mary E Choi; David R Price; Stefan W Ryter; Augustine M K Choi
Journal:  JCI Insight       Date:  2019-08-08

6.  Axonal Degeneration Is Mediated by Necroptosis Activation.

Authors:  Macarena S Arrázola; Cristian Saquel; Romina J Catalán; Sebastián A Barrientos; Diego E Hernandez; Nicolás W Martínez; Alejandra Catenaccio; Felipe A Court
Journal:  J Neurosci       Date:  2019-03-08       Impact factor: 6.167

7.  PPARα exacerbates necroptosis, leading to increased mortality in postinfluenza bacterial superinfection.

Authors:  Vincent C Tam; Rosa Suen; Piper M Treuting; Aaron Armando; Ronald Lucarelli; Norma Gorrochotegui-Escalante; Alan H Diercks; Oswald Quehenberger; Edward A Dennis; Alan Aderem; Elizabeth S Gold
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-24       Impact factor: 11.205

8.  Cutting Edge: Caspase-8 Is a Linchpin in Caspase-3 and Gasdermin D Activation to Control Cell Death, Cytokine Release, and Host Defense during Influenza A Virus Infection.

Authors:  Yaqiu Wang; Rajendra Karki; Min Zheng; Balabhaskararao Kancharana; SangJoon Lee; Sannula Kesavardhana; Baranda S Hansen; Shondra M Pruett-Miller; Thirumala-Devi Kanneganti
Journal:  J Immunol       Date:  2021-10-18       Impact factor: 5.422

9.  Necroptosis: MLKL Polymerization.

Authors:  Andrea Johnston; Zhigao Wang
Journal:  J Nat Sci       Date:  2018-07

10.  Viral dosing of influenza A infection reveals involvement of RIPK3 and FADD, but not MLKL.

Authors:  Teodora Oltean; Emily Van San; Tatyana Divert; Tom Vanden Berghe; Xavier Saelens; Jonathan Maelfait; Nozomi Takahashi; Peter Vandenabeele
Journal:  Cell Death Dis       Date:  2021-05-11       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.